奥沙利铂在结肠癌辅助治疗中的应用 - Suppr

Suppr

超能文献

Oxaliplatin in the adjuvant treatment of colon cancer.

作者信息

Barton Mary Kay

出版信息

CA Cancer J Clin. 2012 Jan-Feb;62(1):3-4. doi: 10.3322/caac.21131. Epub 2011 Nov 16.

DOI:10.3322/caac.21131

PMID:22095255

Abstract

摘要

相似文献

Oxaliplatin in the adjuvant treatment of colon cancer.

CA Cancer J Clin. 2012 Jan-Feb;62(1):3-4. doi: 10.3322/caac.21131. Epub 2011 Nov 16.

Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.

Oncology (Williston Park). 2004 Sep;18(10):1313.

FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.

J Clin Oncol. 2005 May 20;23(15):3311-3. doi: 10.1200/JCO.2005.11.691.

[II. Postoperative adjuvant chemotherapy for colon cancer. 1. Is oxaliplatin combination the most effective chemotherapy for colon cancer?].

Gan To Kagaku Ryoho. 2012 Nov;39(11):1642-.

Oxaliplatin (Eloxatin) for advanced colon cancer.

Med Lett Drugs Ther. 2003 Jan 20;45(1148):7-8.

Oxaliplatin or irinotecan as adjuvant therapy for colon cancer: the results are in.

J Clin Oncol. 2009 Jul 1;27(19):3082-4. doi: 10.1200/JCO.2009.22.2919. Epub 2009 May 18.

Adjuvant therapy of colon cancer: current status and future directions.

Cancer J. 2007 May-Jun;13(3):192-7. doi: 10.1097/PPO.0b013e318074d26e.

[II. Postoperative adjuvant chemotherapy for colon cancer. 2. Oxaliplatin combination does not help better treatment outcome].

Gan To Kagaku Ryoho. 2012 Nov;39(11):1646-9.

New therapeutic options in colon cancer: focus on oxaliplatin.

Clin J Oncol Nurs. 2002 May-Jun;6(3):131-7. doi: 10.1188/02.CJON.131-137.

Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.

Anticancer Drugs. 2007 Mar;18(3):297-300. doi: 10.1097/CAD.0b013e3280102f4b.

引用本文的文献

Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer.

Front Mol Biosci. 2021 Oct 15;8:763652. doi: 10.3389/fmolb.2021.763652. eCollection 2021.

A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling.

Front Oncol. 2021 May 7;11:644956. doi: 10.3389/fonc.2021.644956. eCollection 2021.

Pharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells.

Br J Cancer. 2021 Apr;124(8):1411-1420. doi: 10.1038/s41416-021-01272-6. Epub 2021 Feb 9.

Association between glioblastoma cell-derived vessels and poor prognosis of the patients.

Cancer Commun (Lond). 2020 May;40(5):211-221. doi: 10.1002/cac2.12026. Epub 2020 May 2.

Overexpression of long non-coding RNA colon cancer-associated transcript 2 is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.

Oncol Lett. 2017 Dec;14(6):6907-6914. doi: 10.3892/ol.2017.7049. Epub 2017 Sep 25.

Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer.

Aging (Albany NY). 2017 Mar 18;9(3):914-931. doi: 10.18632/aging.101200.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验